What are the recent financial highlights of EMCURE PHARMACEUTICALS L?

EMCURE PHARMACEUTICALS L recently reported a total revenue of ₹7,551.11 Cr and a net profit margin of 8.05%. These metrics reflect the company’s consistent financial performance.

What are the key financial metrics of EMCURE PHARMACEUTICALS L?

Key financial metrics include a trailing P/E ratio of 28.879713, forward P/E of 18.564705, book value of ₹218.648, price-to-book ratio of 4.238548, and a market capitalization of ₹175.60 billion.

What does EMCURE PHARMACEUTICALS L do?

Emcure Pharmaceuticals Limited engages in the developing, manufacturing, and marketing pharmaceutical products worldwide. It offers products in various therapeutic areas, such as gynecology, cardiovascular, anti-infectives, HIV antivirals, respiratory, gastrointestinal, pain and analgesics, blood related, oncology/anti-neoplastics, anti-diabetic, hormones, neurology/central nervous system, dermatology, and other areas, as well as vitamins, minerals, and nutrients. The company also develops products across various platforms, including chiral molecules, complex APIs, orals, iron products, photo-chemistry products, liposomal and lyophilized injectables, high potency drugs, biotherapeutics, and novel drug delivery systems. It provides its products under Orofer, Bevon, Maxtra, Zostum, Metpure, and Eslo brand names. Emcure Pharmaceuticals Limited was incorporated in 1981 and is based in Pune, India.

Loading...

₹ 0 0.00%

Loading... BSE: Loding... NSE: Emcure

About

Loading... ^[1]

Website BSE NSE

Market Cap ₹ 0 Cr.
Current Price ₹ 0
High / Low ₹ 0 / 0
Stock P/E
Dividend Yield 0 %
ROE 0 %
EPS 0
P/B Ratio 0
Net Profit Margin 0 %
Debt to Equity 0
ROCE 0 %
Interest Coverage 0 %

Stock News - Emcure

Latest updates related to Emcure

Sr No.	Title	Sentiment
1	Stock Radar: Lupin, Cummins, NHPC, SAIL, ITD Cementation, Astral, Emami, RVNL, Indian Hotels, Emcure... Moneycontrol	🔄
2	Upcoming IPOs this week: Emcure Pharma IPO to Ambey Labs- 5 listings and 1 new issue listed The Financial Express	🔄
3	Emcure Pharmaceuticals share gains on foraying into daily supplements space Business Standard	🔄
4	Vidya Balan & Emcure team up to break women health taboos Healthcare Radius	🔄
5	Emcure Expands OTC Portfolio With Arth Supplements, Names Vidya Balan As Brand Ambassador BW Healthcare World	🔄
6	Emcure onboards Vidya Balan as brand ambassador for its Arth range afaqs!	🔄
7	Emcure enters daily supplements market, ropes in Vidya Balan as brand ambassador The Financial Express	🔄
8	Emcure onboards Vidya Balan as brand ambassador Exchange4Media	🔄
9	Emcure Pharma gets Form 483 with two observations for API plant from USFDA The Economic Times	🔄
10	Emcure Pharmaceuticals forays into daily supplements space Business Standard	🔄

Peer Comparison

Macro Industry: Loading.. | Sector: Loading.. | Industry: Loading.. | Basic Industry: Loading..

Loading peers table...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Loading data...

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Loading Profit & Loss data...

Compounded Sales Growth
10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth
10 Years:
5 Years:
3 Years:
TTM:

Stock Price CAGR
10 Years:
5 Years:
3 Years:
1 Year:

Return on Equity
10 Years:
5 Years:
3 Years:
Last Year:

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Shareholding Pattern

Numbers in percentages

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Delivery Data

Insider Data

Technical Data

Static Application Security Testing

Documents

Announcements

Annual reports

Right Issue

Credit ratings

Concalls

Explore More Stocks

CYBERMEDIA TALBROAUTO GVPTECH APTECHT HIRECT KELLTONTEC IDENTICAL MANCREDIT SATECH NH